Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
4.75 GBX | -7.41% | -4.94% | -20.50% |
Oct. 11 | FTSE 100 Finishes Slightly Lower After Steady Session | DJ |
Oct. 11 | Synairgen names Phytome's Joseph Colliver as CFO | AN |
Sales 2023 * | - | Sales 2024 * | - | Capitalization | 10.33M 13.04M |
---|---|---|---|---|---|
Net income 2023 * | -9M -11.36M | Net income 2024 * | - | EV / Sales 2023 * | - |
Net Debt 2023 * | 650K 820K | Net Debt 2024 * | 5.5M 6.94M | EV / Sales 2024 * | - |
P/E ratio 2023 * |
-1.07
x | P/E ratio 2024 * |
-
| Employees | 34 |
Yield 2023 * |
117% | Yield 2024 * |
136% | Free-Float | 96.68% |
1 day | -7.41% | ||
1 week | -4.94% | ||
Current month | -3.59% | ||
1 month | -5.42% | ||
3 months | -22.51% | ||
6 months | -35.37% | ||
Current year | -20.50% |
Managers | Title | Age | Since |
---|---|---|---|
Richard Marsden
CEO | Chief Executive Officer | 57 | 03-10-31 |
Joseph Colliver
DFI | Director of Finance/CFO | 43 | Nov. 05 |
Marcin Mankowski
CTO | Chief Tech/Sci/R&D Officer | - | 23-10-02 |
Members of the board | Title | Age | Since |
---|---|---|---|
Simon Shaw
CHM | Chairman | 59 | 03-05-31 |
Stephen Holgate
FOU | Founder | 77 | 03-05-31 |
Richard Marsden
CEO | Chief Executive Officer | 57 | 03-10-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 4.75 | -7.41% | 18 838 |
24-03-27 | 5.13 | -0.77% | 305,261 |
24-03-26 | 5.17 | +3.50% | 200,284 |
24-03-25 | 4.995 | -5.70% | 770,995 |
24-03-22 | 5.297 | +6.00% | 335,662 |
Delayed Quote London S.E., March 28, 2024 at 07:30 am EDT
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-20.50% | 13.04M | |
+9.16% | 45.97B | |
+54.42% | 43.93B | |
+11.20% | 42.34B | |
-8.59% | 28.27B | |
+16.40% | 27.18B | |
-19.34% | 19.44B | |
+13.95% | 13.83B | |
+31.56% | 12.4B | |
+10.63% | 11.45B |